Home » Journals & Newsletters » CME Tests for CAPN
Following are online CME tests for Child & Adolescent Psychopharmacology News:
Following are online CME tests for Child & Adolescent Psychopharmacology News:
- CME test for CAPN 18(1)
Management of Atypical Antipsychotic Induced Prolactin Elevation in Children and Adolescents by Alice R. Mao, M.D., Nicole D. Garber, M.D., and Catherine S. Mao, M.D.
Reported Financial Relationship: Alice R. Mao, M.D. discloses that she is on the speakers' bureau of Shiongi, Noven, Otsuka, and Shire. Nicole D. Garber, M.D., and Catherine S. Mao, M.D. have no financial relationships to disclose. - CME test for CAPN 17(6)
Anorexia Nervosa and Antipsychotics: How to Apply Research Findings to the Adolescent Population by Helen Burton, B.A. and Adelaide S. Robb, M.D.
Reported Financial Relationship: Helen Burton, B.A.: No financial relationships to disclose. Adelaide S. Robb, M.D.: Grants/Research Support: Bristol Myers Squibb, Forest, Glaxo Smith Kline, Janssen, NICHD, Lundbeck, Merck, Otsuka, Supernus; Consultant: Eli Lilly, Lundbeck, Bristol Myers Squibb, Otsuka; Speaker’s Bureau: Eli Lilly, Bristol Myers Squibb. - CME test for CAPN 17(5)
CAM in Mood Disorders by Molly McVoy, M.D. and Neutraceuticals and Diet Restriction for the Treatment of Attention-Deficit/Hyperactivity Disorder by Griffin A. Stout, M.D.
Reported Financial Relationship: No financial relationships to disclose. - CME test for CAPN 17(4)
CoLT and TEAM: What do the Results Tell Clinicians about Rational Treatment for Pediatric Bipolar Disorder? by Helen Burton, B.A. and Adelaide Robb, M.D.
Reported Financial Relationship: Helen Burton, B.A.: no financial relationships to disclose. Adelaide Robb, M.D.: Grants/Research Support: Bristol Myers Squibb, Forest, Glaxo Smith Kline, Janssen, NICHD, Lundbeck, Merck, Otsuka, Supernus; Consultant: Eli Lilly, Lundbeck, Bristol Myers Squibb, Otsuka; Speaker’s Bureau: Eli Lilly, Bristol Myers Squibb. - CME test for CAPN 17(3)
Evidenced-Based Treatment of PTSD in Children and Adolescents: Where Does Psychopharmacology Fit? by Stacy S. Drury, M.D., Ph.D., and Caitlin Henry, B.A.
Reported Financial Relationship: No financial relationships to disclose. - CME test for CAPN 17(2)
Treatment of Adolescent Alcohol Abuse and Dependence by Sarah B. Johnson, M.D., M.Sc.
Reported Financial Relationship: No financial relationships to disclose.
Target Audience
This CME activity is intended for child and adult psychiatrists, pediatricians and other healthcare professionals with an interest in the psychopharmacology and treatment practices for child and adolescent psychiatric disorders.
Physician Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources and Guilford Publications. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Guilford Publications. The authors have disclosed if any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER or Guilford Publications. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their s conditions and possible contraindications on dangers in use, review of any applicable s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Disclosure of Conflicts of Interest
Medical Education Resources (MER) insures balance, independence, objectivity and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
This CME activity is intended for child and adult psychiatrists, pediatricians and other healthcare professionals with an interest in the psychopharmacology and treatment practices for child and adolescent psychiatric disorders.
Physician Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medical Education Resources and Guilford Publications. Medical Education Resources is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this educational activity for a maximum of 1 AMA PRA Category 1™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources or Guilford Publications. The authors have disclosed if any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER or Guilford Publications. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their s conditions and possible contraindications on dangers in use, review of any applicable s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Disclosure of Conflicts of Interest
Medical Education Resources (MER) insures balance, independence, objectivity and scientific rigor in all our educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, planners, managers and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
